Cargando…
Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
PURPOSE: Influenza CD8(+) T-cell epitopes are conserved amongst influenza strains and can be recognized by influenza-specific cytotoxic T-cells (CTLs), which can rapidly clear infected cells. An influenza peptide vaccine that elicits these CTLs would therefore be an alternative to current influenza...
Autores principales: | Soema, Peter C., Rosendahl Huber, Sietske K., Willems, Geert-Jan, Jiskoot, Wim, Kersten, Gideon F. A., Amorij, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356889/ https://www.ncbi.nlm.nih.gov/pubmed/25344321 http://dx.doi.org/10.1007/s11095-014-1556-3 |
Ejemplares similares
-
Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8(+) T Cell Epitopes
por: Soema, Peter C., et al.
Publicado: (2018) -
Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
por: Soema, Peter Christiaan, et al.
Publicado: (2015) -
Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses
por: Soema, Peter C., et al.
Publicado: (2014) -
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
por: Li, Yibo, et al.
Publicado: (2023) -
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)